Advertisement
Screener

NPS PHARMACEUTICALS INC Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

NPS PHARMACEUTICALS INC Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

NPS PHARMACEUTICALS INC reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$1.98 million for the 3-month period ending 2014-12-31, per its 10-K filed 2015-02-18.

Discontinued › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2015-02-18

  • NPS PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-12-31 was -$1.98M, a 125.42% decline year-over-year.
  • NPS PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-09-30 was -$2.15M.
  • NPS PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-06-30 was $1.99M.
  • NPS PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-03-31 was -$6.58M.
  • NPS PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2011 was -$36.27M.
  • NPS PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2010 was -$31.44M.
  • NPS PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2009 was -$17.86M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month
2014-12-31-$1.98M
10-K · filed 2015-02-18
-$4.12M
derived: sum of 2 quarters · filed 2015-02-18
-$2.13M
derived: sum of 3 quarters · filed 2015-02-18
-$8.71M
derived: sum of 4 quarters · filed 2015-02-18
2014-09-30-$2.15M
10-K · filed 2015-02-18
-$154.00K
derived: sum of 2 quarters · filed 2015-02-18
-$6.73M
derived: sum of 3 quarters · filed 2015-02-18
$1.04M
derived: sum of 4 quarters · filed 2015-02-18
2014-06-30$1.99M
10-K · filed 2015-02-18
-$4.58M
derived: sum of 2 quarters · filed 2015-02-18
$3.18M
derived: sum of 3 quarters · filed 2015-02-18
$2.10M
derived: sum of 4 quarters · filed 2015-02-18
2014-03-31-$6.58M
10-K · filed 2015-02-18
$1.19M
derived: sum of 2 quarters · filed 2015-02-18
$105.00K
derived: sum of 3 quarters · filed 2015-02-18
-$12.28M
derived: sum of 4 quarters · filed 2015-02-18
2013-12-31$7.77M
10-K · filed 2015-02-18
$6.68M
derived: sum of 2 quarters · filed 2015-02-18
-$5.71M
derived: sum of 3 quarters · filed 2015-02-18
-$13.50M
derived: sum of 4 quarters · filed 2015-02-18
2013-09-30-$1.09M
10-K · filed 2015-02-18
-$13.48M
derived: sum of 2 quarters · filed 2015-02-18
-$21.27M
derived: sum of 3 quarters · filed 2015-02-18
-$33.48M
derived: sum of 4 quarters · filed 2015-02-18
2013-06-30-$12.39M
10-K · filed 2015-02-18
-$20.18M
derived: sum of 2 quarters · filed 2015-02-18
-$32.39M
derived: sum of 3 quarters · filed 2015-02-18
-$35.71M
derived: sum of 4 quarters · filed 2015-02-18
2013-03-31-$7.80M
10-K · filed 2015-02-18
-$20.00M
derived: sum of 2 quarters · filed 2015-02-18
-$23.32M
derived: sum of 3 quarters · filed 2015-02-18
-$15.97M
derived: sum of 4 quarters · filed 2015-02-18
2012-12-31-$12.20M
10-K · filed 2014-02-18
-$15.53M
derived: sum of 2 quarters · filed 2014-02-18
-$8.17M
derived: sum of 3 quarters · filed 2014-02-18
-$18.73M
derived: sum of 4 quarters · filed 2014-02-18
2012-09-30-$3.32M
10-K · filed 2014-02-18
$4.03M
derived: sum of 2 quarters · filed 2014-02-18
-$6.53M
derived: sum of 3 quarters · filed 2014-02-18
-$15.17M
derived: sum of 4 quarters · filed 2014-02-18
2012-06-30$7.36M
10-K · filed 2014-02-18
-$3.21M
derived: sum of 2 quarters · filed 2014-02-18
-$11.84M
derived: sum of 3 quarters · filed 2014-02-18
-$24.19M
derived: sum of 4 quarters · filed 2014-02-18
2012-03-31-$10.56M
10-K · filed 2014-02-18
-$19.20M
derived: sum of 2 quarters · filed 2014-02-18
-$31.55M
derived: sum of 3 quarters · filed 2014-02-18
-$37.68M
derived: sum of 4 quarters · filed 2014-02-18
2011-12-31-$8.64M
10-K · filed 2013-02-21
-$20.98M
derived: sum of 2 quarters · filed 2013-02-21
-$27.12M
derived: sum of 3 quarters · filed 2013-02-21
-$36.27M
10-K · filed 2012-02-15
2011-09-30-$12.35M
10-K · filed 2013-02-21
-$18.48M
derived: sum of 2 quarters · filed 2013-02-21
-$27.63M
10-Q · filed 2011-11-03
-$34.03M
derived: sum of 4 quarters · filed 2013-02-21
2011-06-30-$6.13M
10-K · filed 2013-02-21
-$15.28M
10-Q · filed 2011-08-02
-$21.68M
derived: sum of 3 quarters · filed 2013-02-21
-$37.37M
derived: sum of 4 quarters · filed 2013-02-21
2011-03-31-$9.15M
10-K · filed 2013-02-21
-$15.55M
derived: sum of 2 quarters · filed 2013-02-21
-$31.24M
derived: sum of 3 quarters · filed 2013-02-21
-$37.54M
derived: sum of 4 quarters · filed 2013-02-21
2010-12-31-$6.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-15
-$22.09M
derived: sum of 2 quarters · filed 2012-02-15
-$28.39M
derived: sum of 3 quarters · filed 2012-02-15
-$31.44M
10-K · filed 2012-02-15
2010-09-30-$15.69M
10-Q · filed 2011-11-03
-$21.99M
derived: sum of 2 quarters · filed 2011-11-03
-$25.04M
10-Q · filed 2011-11-03
2010-06-30-$6.30M
10-Q · filed 2011-08-02
-$9.35M
10-Q · filed 2011-08-02
2009-12-31-$17.86M
10-K · filed 2012-02-15